Home › Infertility › NCT07856082

Opt-IVF for Personalized Medicine for Normal Responders

The Advanced Decision Support Tool, Opt-IVF for Personalized Medicine for IVF Antagonist and Progesterone-Primed Ovarian Stimulation (PPOS) Protocol for Normal Responders

Who can join

Ages 20 to 50 · Women

Inclusion Criteria:

Normal Responders

Exclusion Criteria:

* PCOS and Poor Responders

About the study

A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.

What is being tested

• Opt-IVF (device)
• control (other)

Sponsor: Urmila DIwekar · Participants: 100 · Started: Oct 15, 2026

Contact the study team

• Urmila Diwekar, Ph.D. · Phone: 6308863047
• Sanjay Joag, M.D., Ph.D. · Phone: 6305014451

Official record on ClinicalTrials.gov — NCT07856082

Locations in the U.S.

Conditions

• Infertility

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.